Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and Beyond.
Journal: International journal of MS care
Published: March 01, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivity.
Journal: BJU international
Published: February 01, 2017
The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial.
Journal: The Journal of urology
Published: January 24, 2017
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
Journal: International journal of MS care
Published: December 22, 2016
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.
Journal: Advances in therapy
Published: July 15, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026